Key facts
- Ōura’s last known valuation is $11.0B (Oct 2025).
- It has raised $2.1B; the latest was Later Stage VC ($907.7M) in Oct 2025.
- Notable investors include Alumni Ventures, Fidelity Management & Research Company, Gaingels, Metaplanet Holdings, European Union — 53 tracked in total.
- Status: Privately Held (backing).
Leadership
- Ricky BloomfieldChief Medical Officer
- Avonte Campinha-BacoteChief Legal Officer & Secretary
- Adi ShammoutChief Information Officer
- Dorothy KilroyExecutive
- ·The complete investor list — 53 names
- ·Watchlist + deal alerts for Ōura
- ·The full record, as it builds
Funding rounds
No funding rounds for Ōura are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ōura
Developer of a wellness wearable string designed to track and improve sleep quality and performance. The company's product tracks sleep quality, stages, electrocardiogram level, resting heart rate, and variability, as well as body temperature during the night through an intelligent data-driven plan by detecting changes in blood pulse volume, enabling users to improve their sleep and overall health and align with their natural circadian rhythm.
- Industry
- Therapeutic Devices
- Sector
- Healthcare
- HQ
- Oulu, Finland
- Founded
- 2013
- Employees
- 900
- Website
- ouraring.com/
- Ownership
- Privately Held (backing)
Ōura doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ōura shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ōura in its N-PORT filings yet. We sweep new filings monthly.